JavaScript is disabled. Please enable to continue!

Mobile search icon
Eurofins CellTx >> Resources >> Donor Eligibility Tests

Donor Eligibility Tests

Sidebar Image

Donor Eligibility Tests

ANALYTE AND PACKAGE INSERT METHOD TEST KIT NAME MANUFACTURER TEST TYPE FDA-LICENSED, APPROVED OR CLEARED FOR DONOR SCREENING CE Mark Affixed to Test Kit
HIV 1/2 Antibody Automated/Manual GS HIV-1/2 Plus O EIA Bio-Rad Screening Yes BL125030 Yes
Hepatitis B Surface Antigen Automated/Manual GS HBsAg 3.0 EIA Bio-Rad Screening Yes BL103590 No
Hepatitis B Core Antibody Automated/Manual Anti-HBcore Total ELISA Ortho Screening Yes BL103062 No
Hepatitis C Antibody Automated/Manual Anti-HCV 3.0 ELISA Ortho Screening Yes BL103065 No
HTLV I/II Antibody Automated/Manual Hanti-HTLV I/II ELISA Avioq Screening Yes BL125394 No
Syphilis Non-Treponemal RPR Automated ASI Automated RPR Arlington Scientific, Inc. Screening Yes BK200488 Yes
Syphilis Treponemal CAPTIA-G Manual CAPTIA-G Trinity BioTech Screening Yes K014233 Yes
CMV Antibody 1 / CMV Antibody 2 Automated/Manual Capture-CMV AB (Total) Immucor Screening Yes BK180247 Yes
NAT HIV-1/2, HCV & HBV Automated Procleix Ultrio Elite Assay Panther Grifols Screening Yes BL125652 Yes
NAT - WNV Automated Procleix WNV Assay Panther Grifols Screening Yes BL125121 Yes
Chagas Automated Ortho T. cruzi ELISA Test System Ortho Screening Yes BL125161 Yes
Chlamydia trachomatis (CT) and/or Neisseria gonorrhoeae (GC) Automated GEN-PROBE® Aptima Combo 2® Assay Hologic Detection * 510K K180681 No

*Although there are diagnostic tests available, there are currently no FDA-licensed, approved, or cleared tests for donor screening. In the absence of such screening tests, you must use an FDA-licensed, approved, or cleared diagnostic test labeled for the detection of these organisms in an asymptomatic, low-prevalence population (§ 1271.80(c)). The use of Chlamydia trachomatis and Neisseria gonorrhoeae tests utilizing NAT technology adequately and appropriately reduces the risk of transmission of these relevant communicable disease agents (§ 1271.80(c)).